Haase H J, Kaumeier S, Schwarz H, Gundel A, Linde O K, Maetz H, Scheel R, Stripf A, Stripf L
Acta Psychiatr Belg. 1978 Jan-Feb;78(1):83-8.
The following statements can be made on the basis of our study. 1. The butyrophenone bromperidol is an absolutely effective drug of the series of very high-potency neuroleptics, with a mean neuroleptic threshold dose of 5.6 mg/day. The mean optimum dose is 6 mg/day, and the mean maximum dose reaches 11 mg/day, i.e. twice the neuroleptic threshold dose. 2. The substance is generally well tolerated; when it was administered to one third of all cases in one single dose in the evening, it not only had the same beneficial neuroleptic-antipsychotic effect as on administration t.i.d., but also positively influenced sleep, so that sleep-inducing drugs could be reduced and, in some cases, even dispensed with. This relatively long-lasting effect confirms the finding made in animal experiments.
基于我们的研究可得出以下结论。1. 丁酰苯类药物溴哌利多是一系列高效能抗精神病药物中绝对有效的一种,其平均抗精神病阈剂量为5.6毫克/天。平均最佳剂量为6毫克/天,平均最大剂量达11毫克/天,即抗精神病阈剂量的两倍。2. 该药物总体耐受性良好;当在晚上单次给药于所有病例的三分之一时,它不仅具有与每日三次给药相同的有益抗精神病作用,而且对睡眠有积极影响,从而可以减少甚至在某些情况下停用助眠药物。这种相对持久的效果证实了在动物实验中得出的结果。